Ryvu Therapeutics SA(PL:RVU)
zł 17.20+0.88 (+4.62%)
PL:RVU
Ryvu Therapeutics SA Revenue
zł 17.20
At close:+0.88 (+4.62%)
Want to see PL:RVU full AI Analyst Report?
Ryvu Therapeutics SA (RVU) Revenue
0 Followers
Ryvu Therapeutics SA Revenue
Ryvu Therapeutics SA had a revenue of 11.99M in the quarter ending Jun 30, 2026, with -29.28%. This bring the company's revenue in the last twelve months to 61.86M, Decreased 0.67%. In the fiscal year ending Dec 31, 2025, Ryvu Therapeutics SA had annual revenue of 62.25M with -20.15% growth.
- Revenue (ttm)
- 61.86M
- Revenue Growth
- -11.57%
- P/S Ratio
- 6.39
- Revenue/Employee
- PLN 273,044
- Employees
- 228
- Market Cap
- PLN 397.67M
Revenue Chart
Ryvu Therapeutics SA Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 62.25M | -15.71M | -20.15% |
| Dec 31, 2024 | 77.97M | 31.11M | 66.38% |
| Dec 31, 2023 | 46.86M | 8.06M | 20.76% |
| Dec 31, 2022 | 38.80M | 27.62M | 246.89% |
| Dec 31, 2021 | 11.19M | -4.23M | -27.43% |
| Dec 31, 2020 | 15.41M | -27.15M | -63.79% |
| Mar 31, 2020 | 42.57M | -34.64M | -44.87% |
| Dec 31, 2018 | 77.21M | -10.61M | -12.09% |
| Dec 31, 2017 | 87.82M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.